• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于血糖监测的 cobas 即时检测设备的验证

Validation of cobas pulse point-of-care testing device for blood glucose monitoring.

作者信息

Adelhelm Josefine B H, Jørgensen Charlotte S, Hansen Heidi B, Østertoft Stine B, Nybo Mads, Jørgensen Louise H

机构信息

Department of Clinical Biochemistry, Odense University Hospital, Odense, Denmark.

出版信息

Scand J Clin Lab Invest. 2025;85(4):275-280. doi: 10.1080/00365513.2025.2512382. Epub 2025 May 30.

DOI:10.1080/00365513.2025.2512382
PMID:40444724
Abstract

The aim of this study was to validate the blood glucose point-of-care system, cobas pulse (Roche Diagnostics GmbH), which is the successor to the Accu-Chek Inform II system (Roche Diagnostics GmbH). Since the cobas pulse device is intended to replace an existing device from the same manufacturer, we found it highly relevant to perform an industry-independent validation regarding accuracy and comparability with existing glucose measurement systems. From 40 randomly selected, non-fasting adults capillary and venous blood was drawn simultaneously. Correlation and agreement was evaluated by comparing capillary blood glucose on cobas pulse to plasma glucose on cobas 8000 (Roche Diagnostics GmbH) and capillary blood glucose on ABL800 Flex (Radiometer, Denmark), respectively. The cobas pulse generally showed good agreement with both comparison methods, although the agreement between cobas pulse and ABL800 Flex was better (bias -0.01 mmol/L) than between cobas pulse and cobas 8000 (bias 0.61 mmol/L). Differences between measurements of low blood glucose levels (range 0.5 to 4.8 mmol/L) and higher blood glucose levels (range 9.7 to 15.3 mmol/L) when comparing cobas pulse to ABL800 Flex was also within allowable limits. Altogether, the validation study demonstrated a clinically satisfactory performance of the cobas pulse point-of-care device.

摘要

本研究的目的是验证即时检测血糖系统cobas pulse(罗氏诊断有限公司),它是Accu-Chek Inform II系统(罗氏诊断有限公司)的后续产品。由于cobas pulse设备旨在取代同一制造商的现有设备,我们发现对其准确性以及与现有血糖测量系统的可比性进行独立于行业的验证具有高度相关性。从40名随机选择的非空腹成年人中同时采集毛细血管血和静脉血。通过分别比较cobas pulse上的毛细血管血糖与cobas 8000(罗氏诊断有限公司)上的血浆血糖以及ABL800 Flex(丹麦雷度米特公司)上的毛细血管血糖,评估相关性和一致性。cobas pulse与两种比较方法总体上均显示出良好的一致性,不过cobas pulse与ABL800 Flex之间的一致性(偏差 -0.01 mmol/L)优于cobas pulse与cobas 8000之间的一致性(偏差0.61 mmol/L)。在比较cobas pulse与ABL800 Flex时,低血糖水平(范围0.5至4.8 mmol/L)和高血糖水平(范围9.7至15.3 mmol/L)测量值之间的差异也在允许范围内。总之,验证研究表明cobas pulse即时检测设备在临床上具有令人满意的性能。

相似文献

1
Validation of cobas pulse point-of-care testing device for blood glucose monitoring.用于血糖监测的 cobas 即时检测设备的验证
Scand J Clin Lab Invest. 2025;85(4):275-280. doi: 10.1080/00365513.2025.2512382. Epub 2025 May 30.
2
Point-of-Care Testing Glucometer in Rapid Assessment Settings: Comparison of 2 Network-Capable Devices in a Referral Hospital.快速评估环境下的即时检测血糖仪:转诊医院中两款具备联网功能设备的比较
J Appl Lab Med. 2025 Jul 1;10(4):963-968. doi: 10.1093/jalm/jfaf048.
3
Hybrid closed-loop systems for managing blood glucose levels in type 1 diabetes: a systematic review and economic modelling.用于管理1型糖尿病患者血糖水平的混合闭环系统:系统评价与经济建模
Health Technol Assess. 2024 Dec;28(80):1-190. doi: 10.3310/JYPL3536.
4
Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.用于管理1型糖尿病患者血糖水平的集成式传感器增强泵治疗系统[美敦力MiniMed® Paradigm™ Veo系统以及Vibe™和G4® PLATINUM连续血糖监测(CGM)系统]:一项系统综述与经济学评估
Health Technol Assess. 2016 Feb;20(17):v-xxxi, 1-251. doi: 10.3310/hta20170.
5
Glucometer versus analyzer: comparable results with negligible clinical risk.
Scand J Clin Lab Invest. 2025 Feb;85(1):11-19. doi: 10.1080/00365513.2025.2456917. Epub 2025 Jan 25.
6
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
7
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
8
Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline.孕前糖尿病与妊娠:内分泌学会和欧洲内分泌学会联合临床实践指南
Eur J Endocrinol. 2025 Jun 30;193(1):G1-G48. doi: 10.1093/ejendo/lvaf116.
9
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.样本采集部位和采集程序对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染鉴定的影响。
Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780.
10
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.